Sagittarius Life Science

TWO:3205 Taiwan Biotechnology
Market Cap
$103.91 Million
NT$3.44 Billion TWD
Market Cap Rank
#20624 Global
#1088 in Taiwan
Share Price
NT$50.90
Change (1 day)
-0.59%
52-Week Range
NT$21.85 - NT$61.00
All Time High
NT$289.67
About

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

Sagittarius Life Science - Asset Resilience Ratio

Latest as of September 2025: 58.55%

Sagittarius Life Science (3205) has an Asset Resilience Ratio of 58.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$652.00 Million
Cash + Short-term Investments
Total Assets
NT$1.11 Billion
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Sagittarius Life Science's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Sagittarius Life Science's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$652.00 Million 58.55%
Total Liquid Assets NT$652.00 Million 58.55%

Asset Resilience Insights

  • Very High Liquidity: Sagittarius Life Science maintains exceptional liquid asset reserves at 58.55% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Sagittarius Life Science Industry Peers by Asset Resilience Ratio

Compare Sagittarius Life Science's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Sagittarius Life Science (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Sagittarius Life Science.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 14.83% NT$77.11 Million NT$519.83 Million +2.57pp
2023-12-31 12.26% NT$81.49 Million NT$664.72 Million -1.60pp
2022-12-31 13.86% NT$80.24 Million NT$579.12 Million -1.42pp
2021-12-31 15.28% NT$103.25 Million NT$675.75 Million +14.45pp
2020-12-31 0.83% NT$6.15 Million NT$740.74 Million +0.34pp
2019-12-31 0.49% NT$4.00 Million NT$811.59 Million -8.32pp
2016-12-31 8.81% NT$124.50 Million NT$1.41 Billion --
pp = percentage points